Ask the Expert: Newly Approved Liver Directed Treatment for Uveal Melanoma

Click Here to Register Today! Join us Tuesday, October 3 at 7:00pm ET to learn more about the latest FDA-approved drug for metastatic uveal melanoma: melphalan delivered directly to the liver. The interactive webinar will feature Jonathan S. Zager, MD, FACS, FSSO, Chief Academic Officer Director of Regional Therapies, and Professor of Surgery, University of South … Continued